% | $
Quotes you view appear here for quick access.

Compugen Ltd. (CGEN) Message Board

  • patworth123 patworth123 Sep 29, 2010 1:37 PM Flag

    New Patent

    another compugen patent 7,803,379 9/28/10

    Tumour-specific animal proteins

    CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal cancers, autoimmune diseases, and related conditions.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Correction,...

      The assignee is:
      GlaxoSmithKline Biologicals S.A. (Rixensart, BE)

      *not* Compugen.

      I'm not an expert in patents.. but believe that the patent owner is listed in the "assignee" field.

      In the particular patent you highlighted (7,803,379 )... a document published by Compugen was referenced in the patent details, but GlaxoSmithKline has right to this patent.

7.42-0.14(-1.85%)Mar 30 4:00 PMEDT